Downregulation of HOTAIR Expression Mediated Anti-Metastatic Effect of Artesunate on Cervical Cancer by Inhibiting COX-2 Expression
暂无分享,去创建一个
Hua Qian | Mei Lin | Junxing Huang | Dong-lan Yuan | M. Sha | Z. Luan | Xiaokang Li | Li-Xing Zhang | Lihua Ye
[1] R. Einspanier,et al. Down regulated lncRNA MEG3 eliminates mycobacteria in macrophages via autophagy , 2016, Scientific Reports.
[2] P. Petignat,et al. Cervical cancer screening in developing countries at a crossroad: Emerging technologies and policy choices. , 2015, World journal of clinical oncology.
[3] Jiandie D. Lin,et al. Long Noncoding RNAs: A New Regulatory Code in Metabolic Control. , 2015, Trends in biochemical sciences.
[4] Weipei Zhu,et al. Up-regulation of long non-coding RNA CCAT2 correlates with tumor metastasis and poor prognosis in cervical squamous cell cancer patients. , 2015, International journal of clinical and experimental pathology.
[5] D. Nam,et al. Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis , 2015, Oncotarget.
[6] L. Fan,et al. High MALAT1 expression predicts a poor prognosis of cervical cancer and promotes cancer cell growth and invasion. , 2015, European review for medical and pharmacological sciences.
[7] A. Bhan,et al. LncRNA HOTAIR: A master regulator of chromatin dynamics and cancer. , 2015, Biochimica et biophysica acta.
[8] H. Zhang,et al. PLK1 and HOTAIR Accelerate Proteasomal Degradation of SUZ12 and ZNF198 during Hepatitis B Virus-Induced Liver Carcinogenesis. , 2015, Cancer research.
[9] Young Tae Kim,et al. Long non-coding RNA HOTAIR is associated with human cervical cancer progression , 2014, International journal of oncology.
[10] W. Hou,et al. Expressions of survivin, P16(INK4a), COX-2, and Ki-67 in cervical cancer progression reveal the potential clinical application. , 2015, European journal of gynaecological oncology.
[11] Zhenjie Wu,et al. Long noncoding RNA HOTAIR can serve as a common molecular marker for lymph node metastasis: a meta-analysis , 2014, Tumor Biology.
[12] Chen Xu,et al. Long Noncoding RNA-EBIC Promotes Tumor Cell Invasion by Binding to EZH2 and Repressing E-Cadherin in Cervical Cancer , 2014, PloS one.
[13] Jun Ye,et al. Artesunate exerts an anti‐immunosuppressive effect on cervical cancer by inhibiting PGE2 production and Foxp3 expression , 2014, Cell biology international.
[14] H. Peh,et al. Artemisinins: pharmacological actions beyond anti-malarial. , 2014, Pharmacology & therapeutics.
[15] J. Rinn,et al. Scaffold function of long non-coding RNA HOTAIR in protein ubiquitination , 2013, Nature Communications.
[16] Jianpeng Xiao,et al. Prognostic significance of cyclooxygenase‐2 in cervical cancer: A meta‐analysis , 2013, International journal of cancer.
[17] F. Landoni,et al. Management of recurrent cervical cancer: a review of the literature. , 2012, Surgical oncology.
[18] Yan-mei Yang,et al. COX-2 expression is correlated with VEGF-C, lymphangiogenesis and lymph node metastasis in human cervical cancer. , 2011, Microvascular research.
[19] D. Reinberg,et al. Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA. , 2010, Genes & development.
[20] Devanand L. Luthria,et al. Flavonoids from Artemisia annua L. as Antioxidants and Their Potential Synergism with Artemisinin against Malaria and Cancer , 2010, Molecules.
[21] S. Zahler,et al. Multimodal therapy for synergic inhibition of tumour cell invasion and tumour-induced angiogenesis , 2010, BMC Cancer.
[22] R. He,et al. Progress in research on the anti-tumor effect of artesunate , 2008, Chinese journal of integrative medicine.
[23] A. Jazaeri,et al. Cyclooxygenase-2 in cervical neoplasia: a review. , 2008, Gynecologic oncology.
[24] P. Suprasert,et al. Radical hysterectomy for stage IIB cervical cancer: a review , 2004, International Journal of Gynecologic Cancer.